Researchers found that, although antibody evolution is highly chaotic at the level of individual cells, germinal centers reliably produce stronger antibodies through repeated rounds of mutation and selection that are only slightly biased toward success. The findings provide a new quantitative framework for understanding immune evolution, with potential implications for vaccine design. This work also lays the groundwork for how germinal centers could serve as an experimentally tractable system for studying evolution more broadly and in real time.

BUFFALO, NY — June 5, 2026 — A new review was published in Volume 18 of Aging on May 15, 2026, titled “Blue period – features of senescence 30 years after beta-galactosidase.”

A new review in the Journal of Pancreatology explores TIGIT as a pivotal immune checkpoint for cancer immunotherapy. It details TIGIT’s immunosuppressive mechanisms, its correlation with poor prognosis, and the superior efficacy of anti-TIGIT/PD-1 combination therapy in overcoming resistance to conventional immune checkpoint inhibitors.

Researchers at Yokohama City University, Japan, have uncovered evidence that the Y chromosome gene UTY still retains regulatory activity in human embryonic stem cells, offering a rare glimpse into what may represent an evolutionary transitional state of the human Y chromosome.

Researchers developed MARVAL, an automated platform for measuring the shape of brain blood vessels from time-of-flight magnetic resonance angiography. In more than 3,000 community participants and nearly 9,000 stroke patients with high-quality imaging, the team built an East Asian cerebrovascular template, charted age-related vascular changes, and found that small-vessel integrity and network complexity were strongly associated with disability, recurrence and mortality after ischemic stroke.

A new study led by XUE Chaoyou from the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences, in collaboration with LOU Huiqiang at China Agricultural University and RAO Shuquan from the Chinese Academy of Medical Sciences has shown that RNA-guided IS110 transposons use two mechanistically distinct pathways to mobilize DNA.